In systemic sclerosis (SSc), new classification criteria highly sensitive to early and limited forms of the disease could facilitate not only the recognition of early SSc, but also the discovery of biomarkers of poor prognosis, with potential benefits for conducting clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alhajeri, H. et al. The 2013 ACR/EULAR classification criteria for systemic sclerosis out-perform the 1980 criteria. Data from the Canadian Scleroderma Research Group. Arthritis Care Res. (Hoboken) http://dx.doi.org/10.1002/acr.22451.
[No authors listed] Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 23, 581–590 (1980).
Nadashkevich, O., Davis, P. & Fritzler, M. J. A proposal of criteria for the classification of systemic sclerosis. Med. Sci. Monit. 10, CR615–CR621 (2004).
Lonzetti, L. S. et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 44, 735–736 (2001).
van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 65, 2737–2747 (2013).
van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747–1755 (2013).
White, B. et al. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum. 38, 351–360 (1995).
Amjadi, S. et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum. 60, 2490–2498 (2009).
LeRoy, E. C. & Medsger, T. A. Criteria for the classification of early systemic sclerosis. J. Rheumatol. 28, 1573–1576 (2001).
Minier, T. et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann.Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-203716.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Asano, Y., Sato, S. New criteria improve recognition of early systemic sclerosis. Nat Rev Rheumatol 11, 3–4 (2015). https://doi.org/10.1038/nrrheum.2014.191
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.191
